HomeAI · summaries
Storia in 3 fonti
What To Know About This IBD 50 Stock's 'Blowout' Quarter
Natera stock surged Friday after reporting "blowout volume" for its cancer-detecting blood test, Signatera.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
investors.com
Natera Eyes Massive New Cancer Market; In Buy Zone With Q2 Report Due
Cancer test name Natera stock is in a buy zone above a cup base ahead of second-quarter results due Thursday.
- ·
forbes.com
Natera Shares Soar Over 20% To All-Time High
Natera shares rocketed Friday as the company reported a strong revenue beat.
